Krystal Biotech KRYS
NASDAQ KRYS
$325.31 -7.25 (-2.18%)
At close: Oct 1, 2026 · 4:00 PM EDT

Krystal Biotech (KRYS) EV to FCF (2024 - 2026)

Updated

Krystal Biotech's EV to FCF was 39.39 in Q2 2026, up 121.7% from 17.76 a year earlier and up 37.9% from the prior quarter.

Analysis

Krystal Biotech (KRYS) EV to FCF (2024 - 2026) Analysis & Trends

On a trailing twelve-month basis, Krystal Biotech's EV to FCF was 30.15 through Jun 30, 2026, up 274.8% year-over-year; for FY2025, it was 33.71, up 2.7% from FY2024.

  • In earlier years, EV to FCF was 32.84 in FY2024.
  • The Q2 2026 figure marks the highest quarterly EV to FCF since Q3 2024.
  • Compared with a year earlier, EV to FCF was higher in two of the last four quarters, with growth averaging 9.5%.
  • Per Business Quant data, KRYS's EV to FCF in the three quarters before Q2 2026 was 28.56 (Q1 2026), 33.71 (Q4 2025) and 26.48 (Q3 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Johnson & Johnson 638.12 Bn 556.64 Bn 17.26 Bn
2 AbbVie 462.60 Bn 435.75 Bn 12.70 Bn
3 Merck 358.70 Bn 313.13 Bn 12.21 Bn
4 Novartis Ag 272.16 Bn 228.03 Bn 11.24 Bn
5 Astrazeneca 250.36 Bn 223.92 Bn 12.86 Bn
6 Amgen 227.87 Bn 183.27 Bn 7.24 Bn
7 Gilead Sciences 184.97 Bn 159.08 Bn 6.22 Bn
8 Pfizer 162.61 Bn 109.56 Bn 10.94 Bn
9 Vertex Pharmaceuticals 132.45 Bn 104.46 Bn 2.84 Bn
10 Krystal Biotech 9.84 Bn 6.61 Bn 112.79 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 39.39
Mar 31, 2026 28.56
Dec 31, 2025 33.71
Sep 30, 2025 26.48
Jun 30, 2025 17.76
Mar 31, 2025 35.52
Dec 31, 2024 32.84
Sep 30, 2024 80.02
API Access

Krystal Biotech EV to FCF API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=ev-to-fcf&ticker=KRYS&period=max&api_key=YOUR_API_KEY